356 related articles for article (PubMed ID: 16574546)
1. Nodal dissection for patients with gastric cancer: a randomised controlled trial.
Wu CW; Hsiung CA; Lo SS; Hsieh MC; Chen JH; Li AF; Lui WY; Whang-Peng J
Lancet Oncol; 2006 Apr; 7(4):309-15. PubMed ID: 16574546
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
3. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
4. Does D2 plus para-aortic nodal dissection surgery offer a better survival outcome compared to D2 surgery only for gastric cancer consistently? A definite result based on a hospital population of nearly two decades.
Zhang Y; Tian S
Scand J Surg; 2013; 102(4):251-7. PubMed ID: 24056132
[TBL] [Abstract][Full Text] [Related]
5. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
6. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
7. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial.
Wu CW; Chiou JM; Ko FS; Lo SS; Chen JH; Lui WY; Whang-Peng J
Br J Cancer; 2008 Jan; 98(1):54-9. PubMed ID: 18182977
[TBL] [Abstract][Full Text] [Related]
8. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
9. Extended lymph-node dissection for gastric cancer.
Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
[TBL] [Abstract][Full Text] [Related]
10. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?
Sun D; Gong R; Wu H
Surg Oncol; 2012 Mar; 21(1):e7-11. PubMed ID: 22071221
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
Wu CW; Hsiung CA; Lo SS; Hsieh MC; Shia LT; Whang-Peng J
Br J Surg; 2004 Mar; 91(3):283-7. PubMed ID: 14991627
[TBL] [Abstract][Full Text] [Related]
12. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
13. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
[TBL] [Abstract][Full Text] [Related]
14. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.
; Buunen M; Veldkamp R; Hop WC; Kuhry E; Jeekel J; Haglind E; PĂ„hlman L; Cuesta MA; Msika S; Morino M; Lacy A; Bonjer HJ
Lancet Oncol; 2009 Jan; 10(1):44-52. PubMed ID: 19071061
[TBL] [Abstract][Full Text] [Related]
15. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
16. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
17. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 May; 13(5):659-67. PubMed ID: 16538414
[TBL] [Abstract][Full Text] [Related]
18. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
Sasako M; Sano T; Yamamoto S; Kurokawa Y; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K;
N Engl J Med; 2008 Jul; 359(5):453-62. PubMed ID: 18669424
[TBL] [Abstract][Full Text] [Related]
19. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
[TBL] [Abstract][Full Text] [Related]
20. Gastric carcinoma: does lymph node dissection alter survival?
Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]